官方网站:http://www.sciencedirect.com/science/journal/13596446
投稿网址:http://ees.elsevier.com/drudis/default.asp?acw=3
PMC链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1359-6446%5BISSN%5D
当前药物发现为发现界提供了最新、最有见地的评论。该杂志不仅论述了药物发现相关技术的快速科学发展,还论述了管理、商业和监管问题,这些问题在研发计划、结构和执行过程中日益发挥作用。特点包括国际专家的评论、重要进展的新闻和分析、关键科学和战略问题的回顾、特定治疗领域最近进展的概述和会议报告。覆盖范围包括:?新的治疗策略?高通量筛选?治疗目标?组合化学、并行合成和库设计?药物输送AdMe/Tox?关键化合物类别和治疗领域的进展?基因组学和蛋白质组学?自动化和技术?虚拟化学?信息学?业务战略?临床试验以及药物发现的其他方面。
Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed.Features include comment by international experts, news and analysis of important developments, reviews of key scientific and strategic issues, overviews of recent progress in specific therapeutic areas and conference reports. Coverage includes: ? Novel therapeutic strategies ? High-throughput screening ? Therapeutic targets ? Combinatorial chemistry, parallel synthesis and library design ? Drug delivery ? ADME/Tox ? Advances in key compound classes and therapeutic areas ? Genomics and proteomics ? Automation and technology ? Virtual chemistry ? Informatics ? Business strategy ? Clinical trials and other aspects of drug discovery.
大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
医学 | 2区 | PHARMACOLOGY & PHARMACY 药学 | 2区 | 否 | 是 |
JCR分区等级 | JCR所属学科 | 分区 | 影响因子 |
Q1 | PHARMACOLOGY & PHARMACY | Q1 | 8.369 |
* 请认真填写需求信息,学术顾问24小时内与您取得联系。